Key result
SARS-CoV-2 infection induced significant transcriptional remodeling in subcutaneous adipose tissue during the subacute phase, but no persistent viral RNA was detected and no consistent gene expression changes were associated with Long COVID.
Why the study?
Adipose tissue has been proposed as a potential reservoir for viral persistence and tissue dysfunction contributing to Long COVID symptoms, but mechanisms driving Long COVID remain poorly elucidated.
Does SARS-CoV-2 persist in subcutaneous adipose tissue and cause transcriptional changes associated with Long COVID?
Observational (n=27)
Yes
Does SARS-CoV-2 persist in subcutaneous adipose tissue and cause transcriptional changes associated with Long COVID?
Subcutaneous adipose tissue does not appear to be a reservoir for persistent SARS-CoV-2 or play a clear role in Long COVID pathophysiology, despite showing transcriptional changes during subacute infection.
Answers are grounded in this paper and cite their sources.
No viral RNA or transcriptional differences in Long COVID SAT; challenges adipose reservoir hypothesis but leaves open other mechanisms or depots.
Long COVID is a heterogeneous condition characterized by a wide range of symptoms that persist for 90 days or more following SARS-CoV-2 infection. Now more than five years out from the onset of the SARS-CoV-2 pandemic, the mechanisms driving Long COVID are just beginning to be elucidated. Adipose tissue has been proposed as a potential reservoir for viral persistence and tissue dysfunction contributing to symptomology seen in Long COVID. To test this hypothesis, we analyzed subcutaneous adipose tissue (SAT) from two cohorts: participants with subacute COVID-19 (28-89 days post-infection) compared to pre-pandemic controls, and participants with Long COVID compared to those with those classified as "indeterminate" based on the RECOVER-Adult Long COVID Research Index (12-47 months post-infection). We found no evidence of persistent SARS-CoV-2 RNA in adipose tissue in any participant. SAT from participants with subacute COVID-19 displayed significant transcriptional remodeling, including depleted immune activation pathways and upregulated Hox genes and integrin interactions, suggesting resident immune cell exhaustion and perturbations in tissue function. However, no consistent changes in gene expression were observed between Long COVID samples and samples from indeterminant participants. Thus, SAT may contribute to inflammatory dysregulation following COVID-19, but does not appear to play a clear role in Long COVID pathophysiology. Further research is needed to clarify the role of adipose tissue in COVID-19 recovery.
No takes yet. Share an insight, caveat, or question.
DeLine-Caballero et al. (2025) conducted an observational in COVID-19 and Long COVID (n=27). SARS-CoV-2 infection vs. Pre-pandemic controls and indeterminate status participants was evaluated on Presence of SARS-CoV-2 RNA and transcriptional changes in subcutaneous adipose tissue. SARS-CoV-2 infection induced significant transcriptional remodeling in subcutaneous adipose tissue during the subacute phase, but no persistent viral RNA was detected and no consistent gene expression changes were associated with Long COVID.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: